Cardiovascular Sciences Top Management
| CVSCDelisted Stock | USD 0.0001 0.00 0.00% |
Cardiovascular Sciences employs about 6 people. The company is managed by 6 executives with a total tenure of roughly 14 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Evaluation of Cardiovascular Sciences' management performance can provide insight into the firm performance.
Cardiovascular |
Cardiovascular Sciences Management Team Effectiveness
Cardiovascular Sciences' management efficiency ratios could be used to measure how well Cardiovascular Sciences manages its routine affairs as well as how well it operates its assets and liabilities.Some institutional investors establish a significant position in stocks such as Cardiovascular Sciences in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Cardiovascular Sciences, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Cardiovascular Sciences Workforce Comparison
Cardiovascular Sciences is number one stock in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 28,548. Cardiovascular Sciences adds roughly 6.0 in number of employees claiming only tiny portion of equities under Health Care industry.
The company has Profit Margin (PM) of 0.85 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.18 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.18. Cardiovascular Sciences Notable Stakeholders
A Cardiovascular Sciences stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Cardiovascular Sciences often face trade-offs trying to please all of them. Cardiovascular Sciences' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Cardiovascular Sciences' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Larry Hooper | Chief Officer | Profile | |
| Tim Murray | President | Profile | |
| Byron Rambo | Sec, Officer | Profile | |
| Michael DApolito | Pres Wellness | Profile | |
| Brian Schneider | Ex VP | Profile | |
| Sandy Williams | Director Operations | Profile |
About Cardiovascular Sciences Management Performance
The success or failure of an entity such as Cardiovascular Sciences often depends on how effective the management is. Cardiovascular Sciences management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Cardiovascular management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Cardiovascular management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Cardiovascular Sciences Inc., a technology company, focuses on the development of medical products. The company was formerly known as Beverly Hills Weight Loss and Wellness, Inc. and changed its name to Cardiovascular Sciences, Inc. in May 2006. Cardiovascular Sci is traded on OTC Exchange in the United States.
Please note, the presentation of Cardiovascular Sciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Cardiovascular Sciences' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Cardiovascular Sciences' management manipulating its earnings.
Cardiovascular Sciences Workforce Analysis
Traditionally, organizations such as Cardiovascular Sciences use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Cardiovascular Sciences within its industry.Cardiovascular Sciences Manpower Efficiency
Return on Cardiovascular Sciences Manpower
| Revenue Per Employee | 53.6K | |
| Revenue Per Executive | 53.6K | |
| Net Income Per Employee | 28.3K | |
| Net Income Per Executive | 28.3K |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Consideration for investing in Cardiovascular Stock
If you are still planning to invest in Cardiovascular Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cardiovascular Sciences' history and understand the potential risks before investing.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |